Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Cell & Gene Therapy Manufacturing Services Market , by Region, 2019-2027 (USD Billion)
1.2.2. Cell & Gene Therapy Manufacturing Services Market , by Type, 2019-2027 (USD Billion)
1.2.3. Cell & Gene Therapy Manufacturing Services Market , by Indication, 2019-2027 (USD Billion)
1.2.4. Cell & Gene Therapy Manufacturing Services Market , by Application, 2019-2027 (USD Billion)
1.2.5. Cell & Gene Therapy Manufacturing Services Market , by End user, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell & Gene Therapy Manufacturing Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell & Gene Therapy Manufacturing Services Market Dynamics
3.1. Cell & Gene Therapy Manufacturing Services Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. High incidence of cancer and other target diseases
3.1.1.2. Increasing investments in pharmaceutical R&D
3.1.2. Market Restraint
3.1.2.1. High operational costs associated with cell & gene therapy manufacturing
3.1.3. Market Opportunities
3.1.3.1. Rising demand for cell & gene therapies
Chapter 4. Global Cell & Gene Therapy Manufacturing Services Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell & Gene Therapy Manufacturing Services Market , by Type
5.1. Market Snapshot
5.2. Global Cell & Gene Therapy Manufacturing Services Market by Type , Performance - Potential Analysis
5.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
5.4.1. Cell Therapy
5.4.2. Gene Therapy
Chapter 6. Global Cell & Gene Therapy Manufacturing Services Market , by Indication
6.1. Market Snapshot
6.2. Global Cell & Gene Therapy Manufacturing Services Market by Indication, Performance - Potential Analysis
6.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
6.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
6.4.1. Oncology Diseases
6.4.2. Cardiovascular Diseases
6.4.3. Orthopedic Diseases
6.4.4. Other Indications
Chapter 7. Global Cell & Gene Therapy Manufacturing Services Market , by Application
7.1. Market Snapshot
7.2. Global Cell & Gene Therapy Manufacturing Services Market by Application, Performance - Potential Analysis
7.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
7.4.1. Clinical Manufacturing
7.4.2. Commercial Manufacturing
Chapter 8. Global Cell & Gene Therapy Manufacturing Services Market , by End user
8.1. Market Snapshot
8.2. Global Cell & Gene Therapy Manufacturing Services Market by End user, Performance - Potential Analysis
8.3. Global Cell & Gene Therapy Manufacturing Services Market Estimates & Forecasts by End user 2018-2027 (USD Billion)
8.4. Cell & Gene Therapy Manufacturing Services Market , Sub Segment Analysis
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Academic & Research Institutes
8.4.3. Other End Users
Chapter 9. Global Cell & Gene Therapy Manufacturing Services Market , Regional Analysis
9.1. Cell & Gene Therapy Manufacturing Services Market , Regional Market Snapshot
9.2. North America Cell & Gene Therapy Manufacturing Services Market
9.2.1. U.S. Cell & Gene Therapy Manufacturing Services Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. Application breakdown estimates & forecasts, 2018-2027
9.2.1.4. End user breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell & Gene Therapy Manufacturing Services Market
9.3. Europe Cell & Gene Therapy Manufacturing Services Market Snapshot
9.3.1. U.K. Cell & Gene Therapy Manufacturing Services Market
9.3.2. Germany Cell & Gene Therapy Manufacturing Services Market
9.3.3. France Cell & Gene Therapy Manufacturing Services Market
9.3.4. Spain Cell & Gene Therapy Manufacturing Services Market
9.3.5. Italy Cell & Gene Therapy Manufacturing Services Market
9.3.6. Rest of Europe Cell & Gene Therapy Manufacturing Services Market
9.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Snapshot
9.4.1. China Cell & Gene Therapy Manufacturing Services Market
9.4.2. India Cell & Gene Therapy Manufacturing Services Market
9.4.3. Japan Cell & Gene Therapy Manufacturing Services Market
9.4.4. Australia Cell & Gene Therapy Manufacturing Services Market
9.4.5. South Korea Cell & Gene Therapy Manufacturing Services Market
9.4.6. Rest of Asia Pacific Cell & Gene Therapy Manufacturing Services Market
9.5. Latin America Cell & Gene Therapy Manufacturing Services Market Snapshot
9.5.1. Brazil Cell & Gene Therapy Manufacturing Services Market
9.5.2. Mexico Cell & Gene Therapy Manufacturing Services Market
9.6. Rest of The World Cell & Gene Therapy Manufacturing Services Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Charles River Laboratories
10.2.4. Lonza
10.2.5. Catalent, Inc.
10.2.6. Takara Bio Inc.
10.2.7. FUJIFILM Holdings Corporation
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. The Discovery Labs LLC
10.2.10. Cell and Gene Therapy Catapult
Chapter 11. Research Indication
11.1. Research Indication
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption